Erythroid Atypical Chemokine Receptor 1 Deficiency Aggravates Immune-Mediated Kidney Disease.

Saved in:
Bibliographic Details
Title: Erythroid Atypical Chemokine Receptor 1 Deficiency Aggravates Immune-Mediated Kidney Disease.
Authors: Artinger K; Clinical Division of Nephrology, Medical University of Graz, Graz, Austria.; Faculty of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Novitzky-Basso I; Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Klötzer KA; Clinical Division of Nephrology, Medical University of Graz, Graz, Austria., Anto-Michel N; Clinical Division of Cardiology, Medical University of Graz, Graz, Austria., Schabhüttl C; Clinical Division of Nephrology, Medical University of Graz, Graz, Austria., Gutjahr JC; Faculty of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.; Institute of Cell Biology and Immunology Thurgau (BITG), University of Konstanz, Kreuzlingen, Switzerland., Samus M; Faculty of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Hub E; Faculty of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Kirsch AH; Clinical Division of Nephrology, Medical University of Graz, Graz, Austria., Leitinger D; Clinical Division of Nephrology, Medical University of Graz, Graz, Austria., Wernitznig S; Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria., Umeizudike T; Nephrology Unit, Medicine Department, Lagos State University Teaching Hospital, Lagos, Nigeria., Pollheimer M; Institute of Pathology, Medical University of Graz, Graz, Austria., Ulvmar MH; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden., Mooslechner AA; Clinical Division of Nephrology, Medical University of Graz, Graz, Austria.; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria., Bacon A; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, United Kingdom., Eller P; Intensive Care Unit, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Kroneis T; Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria., Kratky D; Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.; BioTechMed-Graz, Graz, Austria., Rosenkranz AR; Clinical Division of Nephrology, Medical University of Graz, Graz, Austria., Eller K; Clinical Division of Nephrology, Medical University of Graz, Graz, Austria.; BioTechMed-Graz, Graz, Austria., Rot A; Faculty of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Source: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2026 Apr 01; Vol. 37 (4), pp. 731-746. Date of Electronic Publication: 2025 Sep 17.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1533-3450
DOI:10.1681/ASN.0000000878